Pitfall #3: Poor Patient Selection Not everyone is a good candidate for GLP-1 therapy, and not every candidate is a good fit for your practice
Not enough research has been done to understand ALA's effects in these groups, although some studies suggest there may be benefits for people with complicated pregnancies
That triple action sets it apart from dual-mechanism peptides and has made it an active subject in metabolic and energy-regulation research
Medicare Advantage plans must give you the same coverage as Original Medicare and should, therefore, cover B12 injections when medically necessary
Hemodynamic effects The very early reduction in CV mortality observed in the EMPA-REG OUTCOME trial and early reduction in heart failure in CANVAS, along with heterogeneity of the hazard ratios (HRs) for the atherosclerotic components of the 3-point major adverse cardiovascular events (MACE-3), suggest that the early cardioprotective mechanism of benefit from SGLT2-i may be related to improved hemodynamic status (5,8,22)